CDH1 and hepatocellular carcinoma: A study in hepatocellular carcinoma found that elevated levels of p130Cas associated with more advanced disease and increased lymph node invasion, and that p130Cas expression also associated with elevated levels of β-Catenin and decreased E-Cadherin expression [67].